Drug Shortage Report for ALVESCO

Last updated on 2020-05-02 History
Report ID 109696
Drug Identification Number 02285614
Brand name ALVESCO
Common or Proper name ciclesonide
Company Name COVIS PHARMA GMBH
Market Status MARKETED
Active Ingredient(s) CICLESONIDE
Strength(s) 200MCG
Dosage form(s) AEROSOL, METERED DOSE
Route of administration INHALATION
Packaging size 120 doses
ATC code R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-04-10
Actual start date 2020-04-10
Estimated end date 2020-04-30
Actual end date 2020-05-01
Shortage status Resolved
Updated date 2020-05-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address GRAFENAUWEG 12
ZUG, ZUG
SWITZERLAND 6300
Company contact information Covis Pharma GmbH Grafenauweg 12 Zug, 6300 Switzerland

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-05-02 English Compare
v9 2020-05-01 French Compare
v8 2020-05-01 English Compare
v7 2020-04-11 English Compare
v6 2020-04-10 French Compare
v5 2020-04-10 English Compare
v4 2020-03-27 French Compare
v3 2020-03-27 English Compare
v2 2020-03-27 French Compare
v1 2020-03-27 English Compare

Showing 1 to 10 of 10